| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,594 | 31,490 | 56,435 | 45,629 | | Cost of Revenue | 42,035 | 24,227 | 39,138 | 30,895 | | | Gross Profit | 21,559 | 7,263 | 17,297 | 14,734 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,030 | 10,915 | 11,071 | 11,309 | | Non Recurring | 13,700 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,171) | (3,652) | 6,226 | 3,425 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 76 | 28 | (19) | 61 | | Earnings Before Interest And Taxes | (4,095) | (3,624) | 6,207 | 3,486 | | Interest Expense | 2,674 | 2,683 | 2,684 | 2,694 | | Income Before Tax | (6,769) | (6,307) | 3,523 | 792 | | Income Tax Expense | (2,175) | (2,752) | 1,790 | 335 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,594) | (3,555) | 1,733 | 457 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,594) | (3,555) | 1,733 | 457 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,594) | ($3,555) | $1,733 | $457 |
|
0.31% Nasdaq 
0.05%
Income Statement
